Published in Blood Weekly, May 29th, 2003
"Significant progress has been made in the prevention and management of many symptoms associated with cancer and its therapy," scientists in the United States report.
"Anemia in cancer may be secondary to blood loss, displacement of normal bone marrow cells by malignant cells, myelotoxic therapy, or the tumor itself. Practitioners may not always adequately assess anemia unless it represents a source of significant symptoms or patient distress," wrote T.W. Gillespie and colleagues, Emory University, School of Medicine.
"Risk factors include platinum-based...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.